Cargando…

IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial

BACKGROUND: The effectiveness and durability of endovascular revascularization therapies for chronic critical limb ischemia (CLI) are challenged by the extensive burden of infrapopliteal arterial disease and lesion-related characteristics (e.g., severe calcification, chronic total occlusions), which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeller, Thomas, Baumgartner, Iris, Scheinert, Dierk, Brodmann, Marianne, Bosiers, Marc, Micari, Antonio, Peeters, Patrick, Vermassen, Frank, Landini, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936931/ https://www.ncbi.nlm.nih.gov/pubmed/24552184 http://dx.doi.org/10.1186/1745-6215-15-63

Ejemplares similares

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: 12-Month Results From the IN.PACT SFA Randomized Trial
por: Tepe, Gunnar, et al.
Publicado: (2015)

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial
por: Schneider, Peter A., et al.
Publicado: (2018)

Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study
por: Brodmann, Marianne, et al.
Publicado: (2022)

Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions: Five-Year Outcomes From the IN.PACT SFA Randomized Trial
por: Laird, John A., et al.
Publicado: (2019)

Three-Year Results of the IN.PACT SFA Japan Trial Comparing Drug-Coated Balloons With Percutaneous Transluminal Angioplasty
por: Soga, Yoshimitsu, et al.
Publicado: (2020)

Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization
por: Wittig, Tim, et al.
Publicado: (2023)

Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study
por: Ansel, Gary M., et al.
Publicado: (2018)

Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial
por: Spreen, Marlon I., et al.
Publicado: (2016)

IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population
por: Chen, Zhong, et al.
Publicado: (2019)

Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis
por: Reijnen, Michel M. P. J., et al.
Publicado: (2023)

Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries
por: van Overhagen, Hans, et al.
Publicado: (2023)

Long‐term outcomes after paclitaxel‐coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study
por: Ko, Young‐Guk, et al.
Publicado: (2022)

Cool Excimer Laser-Assisted Angioplasty vs. Percutaneous Transluminal Angioplasty for Infrapopliteal Arterial Occlusion: A Meta-Analysis and Systematic Review
por: Zhou, Mi, et al.
Publicado: (2022)

Long‐Term Follow‐up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug‐Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia
por: Spreen, Marlon I., et al.
Publicado: (2017)

Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study
por: Reijnen, Michel M. P. J., et al.
Publicado: (2019)

IN.PACT™ Admiral™ drug-coated balloons in peripheral artery disease: current perspectives
por: Torii, Sho, et al.
Publicado: (2019)

Percutaneous transluminal angioplasty.
por: Curry, R., et al.
Publicado: (1982)

Clinical Outcomes of Infrapopliteal Angioplasty in Patients With Critical Limb Ischemia
por: Ryu, Hyeon Min, et al.
Publicado: (2012)

Infrapopliteal angioplasty using a combined angiosomal reperfusion strategy
por: Ambler, G. K., et al.
Publicado: (2017)

Economics of drug‐coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV access trial
por: Chun, Ho Jong, et al.
Publicado: (2022)

Evaluation of angiosome-targeted infrapopliteal endovascular revascularization in critical diabetic limb ischemia
por: Ji, Donghua, et al.
Publicado: (2019)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
por: Teichgräber, Ulf, et al.
Publicado: (2021)

Treatment of infrapopliteal post‐PTA dissection with tack implants: 12‐month results from the TOBA‐BTK study
por: Brodmann, Marianne, et al.
Publicado: (2018)

Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trial
por: Keriel-Gascou, Maud, et al.
Publicado: (2013)

Percutaneous Transluminal Angioplasty of Subclavian Artery Lesions
por: Jahic, Elmir, et al.
Publicado: (2019)

Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
por: Torsello, Giovanni, et al.
Publicado: (2020)

One Year Primary Patency of Infrapopliteal Angioplasty Using Drug- Eluting Balloons: Single Center Experience at King Hussein Medical Center
por: Haddad, Sizeph Edward, et al.
Publicado: (2017)

Infrapopliteal angioplasties for limb salvage in diabetic patients: Does the clinical outcome justify its use?
por: Dayananda, L, et al.
Publicado: (2008)

Sirolimus-Coated Balloon Angioplasty of Infra-popliteal Lesions for the Treatment of Chronic Limb-Threatening Ischemia: Study Protocol for the Randomized Controlled LIMES Study
por: Teichgräber, Ulf, et al.
Publicado: (2022)

A Review of Percutaneous Transluminal Angioplasty in Hemodialysis Fistula
por: Bountouris, Ioannis, et al.
Publicado: (2018)

Design of percutaneous transluminal coronary angioplasty balloon catheters
por: Amstutz, C., et al.
Publicado: (2023)

Percutaneous Transluminal Angioplasty and Stenting Using an Aspiration Catheter
por: Yamamoto, Nobuaki, et al.
Publicado: (2021)

The Importance of Patency in Patients with Critical Limb Ischemia Undergoing Endovascular Revascularization for Infrapopliteal Arterial Disease
por: Baumann, Frederic, et al.
Publicado: (2015)

Current evidence of drug-elution therapy for infrapopliteal arterial disease
por: Spiliopoulos, Stavros, et al.
Publicado: (2019)

Percutaneous transluminal angioplasty in the treatment of stenosis of arteriovenous fistulae for hemodialysis
por: Miquelin, Daniel Gustavo, et al.
Publicado: (2008)

Percutaneous transluminal coronary angioplasty in a child with Kawasaki disease.
por: Min, J. H., et al.
Publicado: (1998)

Chronic limb threatening ischemia and diabetes mellitus: the severity of tibial atherosclerosis and outcome after infrapopliteal revascularization
por: Koivunen, Veerakaisa, et al.
Publicado: (2020)

Influence of Infrapopliteal Runoff Vessels on Primary Patency after Superficial Femoral Artery Angioplasty with Stenting in Patients with Claudication
por: Noh, Byeong Gwan, et al.
Publicado: (2020)

Endovascular Excimer Laser-Assisted Balloon Angioplasty for Infrapopliteal Arteries in Thromboangiitis Obliterans: A Treatment for Acute-Phase TAO
por: Pu, Hongji, et al.
Publicado: (2022)

Successful Revascularization of Infrapopliteal Chronic Total Occlusions Using the Plantar Arch as a Conduit and Retrograde Pedal Access
por: Bob-Manuel, Tamunoinemi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6pjo9see0mol3mmmq3nsuu2l6m